FDA approves new therapy for people living with skin-discoloration disorder vitiligo - ABC News

Opzelura is the first cream approved to treat an autoimmune condition that changes skin color.

The U.S. Food and Drug Administration granted approval on Monday for Opzelura, which is the first topical JAK inhibitor cream for the treatment of vitiligo for people 12 and older. Vitiligo, which r… [+5108 chars]

full article...